Initiated in 1954 to honor Karl Landsteiner, MD, whose lifetime research laid the foundation for modern blood transfusion therapy, this award recognizes a scientist whose original research has resulted in an important contribution to the body of scientific knowledge. The scientist who receives the award should have an international reputation in transfusion medicine or cellular therapies. Recipient is selected by AABB’s Board of Directors.
Recipient:
Anneke Brand, MD, PhD
Professor of Transfusion Medicine, Leiden University Medical Center
Citation:
For her pioneering work on the immunological effects of blood transfusions, particularly on the role of leukocytes in blood products and their ability to modulate immunity.
This award honors Tibor Greenwalt, MD, who was the first registrant at the first AABB Annual Meeting and founding editor of TRANSFUSION. The award recognizes an individual who has made major scientific or clinical contributions to hematology, transfusion medicine or cellular therapies, and succinctly communicated these advances. Recipient is selected by a joint committee composed of leaders from the Cellular Therapies Section Coordinating Committee and the Transfusion Medicine Section Coordinating Committee with formal approval by AABB’s Board of Directors.
Recipient:
Donald L. Siegel, PhD, MD
Professor of Pathology & Laboratory Medicine
Director, Division of Transfusion Medicine & Therapeutic Pathology
Director, Fellowship Program in Transfusion Medicine
Director, Clinical Cell & Vaccine Production Facility
Center for Advanced Cellular Therapies
Perelman School of Medicine University of Pennsylvania
Citation:
For his development and pioneering use of antibody phage display and of antibody and chimeric antigen receptor T cell constructs in transfusion medicine and related disciplines, including autoimmune disease, dermatology,
infectious disease and cancer.
This award began as a lectureship in 1963 and was designated as a Memorial Award in 1983. The Emily Cooley Memorial Award and Lectureship recognizes an individual who has demonstrated teaching ability and has made a major contribution to the field of transfusion medicine or cellular therapies. Recipient is selected by a joint committee composed of leaders from the Cellular Therapies Section Coordinating Committee and the Transfusion Medicine Section Coordinating Committee with formal approval by AABB’s Board of Directors.
Recipient:
Heather Hume MD, FRCPC
Hematologist, Centre Hospitalier Universitaire Sainte-Justine
Clinical Professor, Dept of Pediatrics, University of Montreal
Citation:
For her instrumental work in spearheading the development of a transfusion medicine fellowship training program and guideline development of best practice recommendations for the transfusion of blood components and immunoglobulin
therapy and for her leadership in translating the essentials of best transfusion practices to low-resource settings.
The Sally Frank Memorial Award and Lectureship was established in 1982 in memory of Sally Frank and her dedication to red cell serology and education. This award recognizes an individual who is, or has been, a medical technologist involved with these fields and has demonstrated quality research, teaching and/or service abilities in the technical aspects of immunohematology. Recipient is selected by AABB’s Transfusion Medicine Section Coordinating Committee with formal approval by AABB’s Board of Directors.
Recipient:
Connie M. Westhoff, SBB, PhD
Executive Scientific Director, New York Blood Center
Citation:
For her extensive academic achievements and outstanding track record in teaching and service in the field of immunohematology.
This award, renamed in 2005 after Bernice Hemphill, W. Quinn Jordan, and Joel Solomon, honors leaders from the transfusion medicine and cellular therapy community. The award recognizes an individual who has made significant contributions in the areas of administration, quality programs, law and/or government affairs. The individual has demonstrated leadership qualities and a consistent willingness to lend his/her expertise to his/her peers. The award may recognize one particular act or an accumulation of contributions throughout many years. Recipient is selected by a joint committee composed of leaders from the Cellular Therapies Section Coordinating Committee and the Transfusion Medicine Section Coordinating Committee with formal approval by AABB’s Board of Directors.
Recipient:
Dana Devine, PhD
Chief Scientist, Canadian Blood Services
Professor of Pathology and Laboratory Medicine, University of British Columbia
Citation:
For her extensive contributions in transfusion medicine, particularly in the areas of administration, quality programs, and law/government affairs. Dr. Devine created an integrated research program with strong ties to government
and academic sectors. This model also included direct support for trainees, including PhD students, postdoctoral fellows, and transfusion medicine residents/fellows.
This award, established in 1956, recognizes an individual who has given outstanding service to AABB by demonstrating a willingness to lend his/her expertise to the association through work on committees, the AABB Board of Directors and other areas. The John Elliott Memorial Award is presented in odd years only.
Recipient:
Susan T. Johnson, MSTM, MT(ASCP)SBBCM
Director of Clinical Education, Versiti
Director of the Transfusion Medicine
Program, Marquette University
Associate Director, Indian Immunohematology Initiative
Citation:
For her extraordinary commitment to involvement on various committees and service through her numerous presentations of AABB programs related to Immunohematology and Reference Laboratories.
This award, created in 2002, honors Dale A. Smith, a long-time Baxter Healthcare executive who was responsible for establishing the Fenwal Division of Baxter. This award recognizes groundbreaking work performed in the application of technology to the practice of transfusion medicine or cellular therapies. Recipient is selected by the National Blood Foundation (NBF) Scientific Grants Review Committee with formal approval by the NBF Board of Trustees.
Recipients:
Michael Pandelakis
Founder & CEO, BloodHub
Andrew Pandelakis
Founder & COO, BloodHub
Citation:
For introducing technology that allows electronic unit ordering and reference lab testing, greatly reducing the time and effort that blood suppliers and hospital customers spend on blood ordering, inventory management,
logistics and billing. The initial BloodHub web application automated blood orders and managed inventory and was adaptable to a variety of computer systems. BloodHub technology evolved to take on reference lab testing requests (with automatic notification
of workup status and electronic reporting), hospital product delivery and return transactions, transfers, discards, credits, and a complete unit audit trail, and, later, to include logistics, transportation, dispatchers, drivers, and route optimization.
To complete the order-to-cash cycle, BloodHub created BloodBill which today generates invoices totalling $1 billion annually. BloodHub serves 50,000 users at more than 4,000 hospitals who place 1.8 million orders for nearly 12 million components each
year, representing approximately 65% of the transfusable units in the U.S.
This award was established in 2016 to recognize a scientist whose original research resulted in an important contribution to the body of scientific knowledge in transfusion medicine or cellular therapies. Recipient is selected by the NBF Scientific Grants Review Committee with formal approval by the NBF Board of Trustees.
Recipient:
David Gibb, MD, PhD
Assistant Professor, Division of Transfusion Medicine, Cedars-Sinai Medical Center
Citation:
For his 2016 National Blood Foundation-funded research on characterizing innate immune mechanisms underlying the link between inflammation and RBC alloimmunization. Dr. Gibb generated and utilized mouse transfusion models
to test the role of type 1 interferons (IFNα/β) in alloimmunization to human RBC antigens. Dr. Gibb discovered that IFNα/β receptor signaling is required for alloimmunization to the human KEL antigen expressed on transfused murine
RBCs. Since the completion of his NBF grant in 2018, Dr. Gibb has co-authored eight scientific papers, including a senior author publication.
This award honors the author(s) of the best original research article published each year in TRANSFUSION. It recognizes impeccable study design, innovation, significance, and effective communication in any area of knowledge covered by the journal.
Selection of recipient(s) is a collaborative effort of the journal’s Associate Editors and the NBF Grants Review Committee. (The RISE Award is presented annually.) Recipient Selected by Associate Editors of TRANSFUSION with formal approval by the NBF Grants Review Committee.
Recipient:
“Hypoxic storage of red blood cells improves metabolism and post‐transfusion recovery”
Authors:
Angelo DʼAlessandro, PhD; Tatsuro Yoshida, PhD; Shawnagay Nestheide; Travis Nemkov, PhD; Sarah Stocker; Davide Stefanoni, BS; Fatima Mohmoud; Neeta Rugg, MS; Andrew Dunham, PhD; and Jose A. Cancelas, MD, PhD
Citation:
For their original research article titled “Hypoxic storage of red blood cells improves metabolism and post‐transfusion recovery,” published in the 2020 volume year of TRANSFUSION.
AABB President’s Awards are given every year to recognize the extraordinary public service and contributions of an individual or an organization in the health care arena. The recipients’ work furthers AABB’s goals and missions.
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977